Serum Phenylacetylglutamine Is a Potential Risk Factor for Aortic Stiffness in Patients with Chronic Hemodialysis
<b>Background/Objectives:</b> Phenylacetylglutamine (PAG), a gut microbiota-derived metabolite, may contribute to the development of cardiometabolic diseases. The diagnostic value of PAG for vascular dysfunction in hemodialysis (HD) remains unclear. This study assessed how serum PAG levels relate to...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-12-01
|
| Col·lecció: | Diagnostics |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2075-4418/15/24/3123 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|